Genzyme Corporation Mergers and Acquisitions


Genzyme Corporation

500 Kendall Street
Cambridge, MA 02142
United States
Tel:1/617 252-7600
URL: http://www.genzyme.com
Primary Symbol & Exchange:
GENZ - GENZYME GENERAL DIV (Common Stock) - NASDAQ
Industry:
Biotechnology
Genzyme Corporation Company Snapshot

Genzyme Corporation Deal Timeline


Drag the timeline to see more deals; click on a deal to see details.


Acquisitions > 100 M$ 10 to 100 M$ < 10M$ Stakes Divestitures

Genzyme Corporation M&A History


Genzyme Corp acquires Targeted Genetics Corp-Mnfg As from Targeted Genetics Corp Genzyme Corp acquires  Targeted Genetics Corp-Mnfg As from Targeted Genetics CorpSep 09, 2009

US - Genzyme Corp acquired the manufacturing assets of Targeted Genetics Corp, a biotechnology company, for an estimated USD # mil in cash.

Genzyme Corp acquires Bayer Healthcare-Portfolio from Bayer AG Genzyme Corp acquires Bayer Healthcare-Portfolio from Bayer AGJun 02, 2009

US - Genzyme Corp acquired the hematologic oncology portfolio of Bayer HealthCare Pharmaceuticals Inc, a manufacturer of pharmaceuticals, and a unit of the Bayer HealthCare LLC subsidiary of Bayer AG's Bayer Healthcare AG unit.

Genzyme Corp acquires EXACT Sciences Corp-Certain from EXACT Sciences Corp Genzyme Corp acquires EXACT Sciences Corp-Certain from EXACT Sciences CorpJan 27, 2009

US - Genzyme Corp (GC) acquired certain prenatal and reproductive health assets of EXACT Sciences Corp (ES), a provider of applied genomics technologies and services, for $##.# mil in cash. Concurrently, GC acquired an ##.##% stake, or # mil

Genzyme Corp acquires a minority stake in EXACT Sciences Corp Genzyme Corp acquires a minority stake in EXACT Sciences CorpJan 27, 2009

US - Genzyme Corp (GC) acquired an ##.##% stake, or # mil common shares, in EXACT Sciences Corp (ES), a provider of applied genomics technologies and services, for $# in cash per share, or a total value of $# mil

Genzyme Corp acquires Diagnostic Chem Ltd-Diagnostic from Diamant Co Ltd (pending) Genzyme Corp acquires Diagnostic Chem Ltd-Diagnostic from Diamant Co Ltd (pending)Nov 09, 2007

CANADA - Genzyme Corp agreed to acquire the diagnostic division of Diagnostic Chemicals Ltd, a manufacturer of medical diagnostic products, for ##.### mil Canadian dollars ($## mil US).

Genzyme Corp acquires Bioenvision Inc Genzyme Corp acquires Bioenvision IncJul 10, 2007

US - Genzyme Corp (GC) acquired all the outstanding common stock of Bioenvision Inc (BI), a biotechnology company focused on the acquisition, development and distribution of drugs to treat cancer, for $#.# in cash per share, or a total value

Genzyme Corp launches a tender offer for AnorMED Inc Genzyme Corp launches a tender offer for AnorMED IncNov 07, 2006

CANADA - Genzyme Corp (GC) acquired all the outstanding common stock of AnorMED Inc (AM), a biopharmaceutical company, for a sweetened ##.# Canadian dollars ($##.## US) in cash per share, or a total value of C$###.### mil

Genzyme Corp acquires Brennen Medical Inc-GlucaTex from Brennen Medical Inc Genzyme Corp acquires Brennen Medical Inc-GlucaTex from Brennen Medical IncApr 12, 2006

US - Genzyme Corp acquired the GlucaTex and GlucaMesh product line of Brennen Medical Inc, a manufacturer of medical and surgical products. Terms were not disclosed.

Genzyme Corp acquires Avigen Inc-Gene Therapy Assets from Avigen Inc Genzyme Corp acquires Avigen Inc-Gene Therapy Assets from Avigen IncDec 21, 2005

US - Genzyme Corp acquired the gene therapy assets of Avigen Inc, a developer of gene-based therapeutic products, for $## mil in cash and up to an undisclosed amount in profit related payments.

Genzyme Corp acquires Cell Genesys Inf-Mnfg Op from Cell Genesys Inc Genzyme Corp acquires Cell Genesys Inf-Mnfg Op from Cell Genesys IncNov 22, 2005

US - Genzyme Corp acquired the manufacturing operations, lcoated in San Diego, California, of Cell Genesys Inc, a biotechnology company, for $#.# mil in cash.

Genzyme Corp acquires Bone Care Intl Inc Genzyme Corp acquires Bone Care Intl IncJul 01, 2005

US - Genzyme Corp acquired all the outstanding common stock of Bone Care International Inc, a manufacturer of vitamin D hormone therapeutic products, for $## in cash per share, or a total value of $###.### mil. The transaction was duly

Genzyme Corp acquires Verigen AG Genzyme Corp acquires Verigen AGFeb 07, 2005

GERMANY - Genzyme Corp of the US acquired a ##% interest in Verigen AG, a Leverkusen-based biotechnology company, for ##.### mil euros($## mil US). The consideration was to consist of #.### mil euros($## mil) in cash

Genzyme Corp acquires Wyeth- Sales,Marketing Rights from Wyeth Genzyme Corp acquires Wyeth- Sales,Marketing Rights from WyethJan 06, 2005

US - Genzyme Corp acquired the sales and marketing rights to Synvisc (R) (hylan G-F ##) from Wyeth, a manufactrurer of pharmaceutical products, for $### mil. The consideration consisted of $### mil in cash and up to $### mil in

Genzyme Corp acquires ILEX Oncology Inc Genzyme Corp acquires ILEX Oncology IncDec 21, 2004

US - Genzyme Corp (GC) acquired all the outstanding common stock of ILEX Oncology Inc (IO), a manufacturer of oncology-focused pharmaceuticals, in a stock swap transaction valued at $#.## bil. GC offered $##.## in common stock per IO

Ergomed Clinical Research Ltd acquires Ilex Oncology Inc-Operating from Genzyme Corp Ergomed Clinical Research Ltd acquires Ilex Oncology Inc-Operating from Genzyme CorpJun 21, 2004

UK - Ergomed Clinical Research Ltd of Germany acquired the operating assets of ILEX Oncology Inc, a US-based manufacturer of pharmaceuticals.

Erbomed Clinical Research Ltd acquires Ilex Svcs -Guildford Clinic Lt from Genzyme Corp Erbomed Clinical Research Ltd acquires Ilex Svcs -Guildford Clinic Lt from Genzyme CorpJun 21, 2004

UK - Erbomed Clinical Research Ltd of Germany, acquired the Guildford clinical research & regulatory office of Ilex Services Ltd, a Guildford-based provider of regulatory strategy services, and a unit of Ilex Oncology Inc.

Genzyme Corp acquires Impath Physician Services from Impath Inc Genzyme Corp acquires Impath Physician Services from Impath IncMay 03, 2004

US - Genzyme Corp acquired IMPATH Physician Services, a provider of research and development services for treating cancer, from bankrupt IMPATH Inc, for an estimated $### mil in cash, in an auction process.

Genzyme Corp acquires Alfigen Inc Genzyme Corp acquires Alfigen IncFeb 22, 2004

US - Genzyme Corp acquired Alfigen Inc, an owner and operator of genetic and esoteric testing company. Terms were not disclosed.

Genzyme Corp acquires a minority stake in Cambridge Antibody Tech Grp (pending) Genzyme Corp acquires a minority stake in Cambridge Antibody Tech Grp (pending)Sep 22, 2003

UK - Genzyme Corp planned to raise its stake to ##.###% from #.##%, by acquiring an ##.###% stake, or #.# mil ordinary shares, in Cambridge Antibody Technology Group PLC, a Cambridge-based manufacturer of pharmaceuticals, for ##

Genzyme Corp launches a tender offer for SangStat Medical Corp Genzyme Corp launches a tender offer for SangStat Medical CorpSep 15, 2003

US - Genzyme Corp (GC) completed its tender offer to acquire all the outstanding common stock of SangStat Medical Corp (SSM), a manufacturer and marketer of therapeutic products, for $##.## in cash per share, or a total value of $###

Genzyme Corporation M&A Summary


Genzyme Corporation has made 45 acquisitions while taking stakes in 13 companies. Genzyme Corporation has 17 divestitures during this period.
YearAcquisitionsStakesDivestitures
2009310
2008000
2007100
2006200
2005410
2004302
2003101
2002100
2001403
2000310
1999212
1998101
1997110
1996212
1995121
1994321
1993300
1992422
1991300
1990211
1989100
1988000
1987001
Total451317

Other Recent M&A in the Biotechnology industry